Concert Pharmaceuticals (CNCE) Analysts See $-0.62 EPS; WMS Industries (WMS) Has 1.38 Sentiment

August 3, 2017 - By Ellis Scott

Advanced Drainage Systems, Inc. is engaged in designing, manufacturing and marketing of thermoplastic corrugated pipe and related water management products, primarily in North and South America, and Europe. The company has market cap of $1.11 billion. The Firm operates through two divisions: Domestic and International. It has a 38.61 P/E ratio. The Domestic segment makes and markets products throughout the United States.

Analysts expect Concert Pharmaceuticals Inc (NASDAQ:CNCE) to report $-0.62 EPS on August, 8.They anticipate $0.02 EPS change or 3.33% from last quarter’s $-0.6 EPS. After having $-0.60 EPS previously, Concert Pharmaceuticals Inc’s analysts see 3.33% EPS growth. The stock decreased 1.04% or $0.15 during the last trading session, reaching $14.21. About shares traded. Concert Pharmaceuticals Inc (NASDAQ:CNCE) has risen 18.70% since August 3, 2016 and is uptrending. It has outperformed by 2.00% the S&P500.

Investors sentiment increased to 1.36 in Q4 2016. Its up 0.36, from 1 in 2016Q3. It is positive, as 12 investors sold Concert Pharmaceuticals Inc shares while 21 reduced holdings. 13 funds opened positions while 32 raised stakes. 12.41 million shares or 2.34% less from 12.71 million shares in 2016Q3 were reported. Dafna Cap Mgmt Llc stated it has 0.61% of its portfolio in Concert Pharmaceuticals Inc (NASDAQ:CNCE). Blackrock Inv Management Limited Liability Corporation has 0% invested in Concert Pharmaceuticals Inc (NASDAQ:CNCE) for 71,478 shares. Invesco Limited reported 0% stake. Tiaa Cref Ltd Liability Com invested 0% in Concert Pharmaceuticals Inc (NASDAQ:CNCE). 21,406 were accumulated by Alps. Prelude Cap Mgmt Ltd stated it has 7,100 shares or 0.01% of all its holdings. Schwab Charles holds 21,722 shares. Blackrock Institutional Na owns 433,052 shares. 1,502 are owned by Meeder Asset Incorporated. 19,984 are owned by Manchester Cap Mgmt Ltd Llc. Franklin Resource invested in 687,000 shares. Blackrock stated it has 0% of its portfolio in Concert Pharmaceuticals Inc (NASDAQ:CNCE). Benjamin F Edwards And owns 300 shares for 0% of their portfolio. Blackrock Advisors stated it has 69,847 shares. Numeric Investors Limited Co stated it has 456,681 shares or 0.05% of all its holdings.

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $320.62 million. The Firm is engaged in the discovery and development of small molecule drugs. It currently has negative earnings. The Firm operates through the development of pharmaceutical products on its own behalf or in collaboration with others.

Among 8 analysts covering Concert Pharmaceuticals (NASDAQ:CNCE), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Concert Pharmaceuticals had 12 analyst reports since August 12, 2015 according to SRatingsIntel. Aegis Capital initiated Concert Pharmaceuticals Inc (NASDAQ:CNCE) rating on Wednesday, September 9. Aegis Capital has “Buy” rating and $26 target. The company was maintained on Monday, June 12 by Aegis Capital. The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) has “Market Outperform” rating given on Wednesday, March 9 by JMP Securities. The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) earned “Buy” rating by TH Capital on Tuesday, September 22. As per Monday, November 9, the company rating was downgraded by UBS. On Friday, July 1 the stock rating was initiated by Stifel Nicolaus with “Buy”. On Thursday, June 29 the stock rating was maintained by Aegis Capital with “Buy”. As per Wednesday, August 12, the company rating was initiated by Brean Capital. The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) has “Buy” rating given on Tuesday, September 22 by Roth Capital.

The stock decreased 2.93% or $0.6 during the last trading session, reaching $19.9. About shares traded. Advanced Drainage Systems Inc (WMS) has declined 0.13% since August 3, 2016 and is downtrending. It has underperformed by 16.83% the S&P500.

Analysts await Advanced Drainage Systems Inc (NYSE:WMS) to report earnings on October, 5. They expect $0.33 earnings per share, down 15.38% or $0.06 from last year’s $0.39 per share. WMS’s profit will be $18.41M for 15.08 P/E if the $0.33 EPS becomes a reality. After $-0.34 actual earnings per share reported by Advanced Drainage Systems Inc for the previous quarter, Wall Street now forecasts -197.06% EPS growth.